2024-10-11 14:56:00
On Friday 10 October, from the left and the right, MPs from different political parties urged the government to block the sale of Opella, a subsidiary of Sanofi responsible in particular for the production of Doliprane.
Doliprane, the best-selling drug in France, is about to move under the American flag, after Sanofi announced on Friday that it was in talks with the CD&R investment fund to transfer control of its subsidiary to it.
Several party leaders immediately took to their social networks. “France’s sell-off continues”, Giordano Bardella (National rally). “No lessons will have been learned from Covid”, Marine Tondelier noted (Ecologists). That’s all “a shame” et “another symbol of our loss of sovereignty”, reacted Fabien Roussel (Communist Party).
MPs from all sides, from the left to elected officials who support the government, have also called on the executive to oppose. The operation “represents a very concerning issue for our national security”write about sixty deputies from the groups Ensemble pour la République (ex-Renaissance), Horizons, Démocrate (ex-MoDem) and Republican Right (ex-LR), on the initiative of MP Charles Rodwell (EPR). “Doliprane is an essential medicine for the health of millions of French people”AND “success for the Sanofi group”and the operation would go against the “restoration of French sovereignty in health matters”they warn in a joint letter to the Minister of Economy, Antoine Armand.
“Health sovereignty”
Last Friday it was the deputies of France insoumise who asked the government to block the transfer. “These people are ruining champagne by deindustrializing France”, they reportedevoking “a sale worth 15 billion euros… and in prospect 7 billion in gifts to shareholders”.
The head of the Republican right group, Laurent Wauquiez, and the general rapporteur of the Social Security budget, Yannick Neuder (DR), He also wrote to the minister with the same request: “It is essential that the State acts to protect our industrial flagships and guarantee France’s health sovereignty. »
“Even if paracetamol was already unobtainable a few months ago… are they abandoning it? Neither is it good for our health nor is it good for our work”, the leader of the socialist deputies, Boris Vallaud, denounced on Xinviting the government to do so “react”.
According to reliable sources, the unspecified valuation would be close to 16 billion euros. Opella claims to be number three in the world in non-prescription medicines, vitamins, minerals and nutritional supplements. This subsidiary oversees a hundred brands in addition to Doliprane, such as Mucosolvan, Maalox, and Novanuit.
Buying guides from Le Monde
Reusable water bottles
The best water bottles to replace disposable bottles
Lire
The Ministers of Economy, Antoine Armand, and Industry, Marc Ferracci, asked on Friday for the commitment of Sanofi and the future buyer to guarantee the “maintain offices and decision-making centers on the national territory” et “Opella’s French industrial footprint”.
#politicians #sides #calling #government #prevent #sale #Sanofi #subsidiary #American #fund